Encouraging initial study results boosted a Canadian cannabis stock Friday. Here’s some small stocks making big moves on Friday, January 25, 2019 (as of 4 pm EST):
Aleafia Health Inc. (TSX:ALEF), a Canadian cannabis stock, jumped 21% to $2.12 on Friday after announcing what it believes to be the first study reporting reduced benzodiazepine use among patients initiated and monitored on medical cannabis. The cohort featured 146 patients who received physician-led treatment in Aleafia Health’s wholly-owned Canabo Medical Clinics. Aleafia believes it maintains the world’s largest medical cannabis patient dataset and is deploying the data for unique insights in medical cannabis treatment and product development best practices.
As well, shares of Goldstrike Resources Ltd. (TSXV:GSR) slid 14% to $0.06 as the gold explorer said Newmont Mining has decide to discontinue its option to earn an interest in Goldstrike’s 100% owned Plateau Property in the Yukon.
Khiron Life Sciences Corp. (TSXV:KHRN), meanwhile, reported that it has agreed to acquire NettaGrowth International Inc., an arm’s length party, which will own, at the time of completion of the transaction, all the outstanding shares of Dormul S.A. Dormul has obtained the first license to produce medical cannabis with THC for commercialization in Uruguay. As consideration for the acquisition of NettaGro, Khiron will issue 8,498,821 common shares to the shareholders of NettaGro, at a deemed price of $1.61 per common share. Khiron Life Sciences stock moved up 14% to $1.80 following the announcement.
Aleafia Health Inc. (TSX:ALEF) is a featured sponsored company and has paid SmallCapPower.com a fee for coverage. To learn more, see our full disclosure HERE >>
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.